Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Researchers seek sharper MRI images in new study

NCT ID NCT01130545

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 8 times

Summary

This study aims to improve how MRI scans are done by testing new imaging techniques on up to 1,000 healthy volunteers and people with cardiac risk factors. Participants will have one or more MRI scans over a few years, with some receiving a contrast dye. The goal is to refine current methods and develop better ways to capture clear images of the body.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2010

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Volunteers (maybe Volunteers, NIH employee and current NIH protocol participants)

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: A. Volunteer individuals B. Lab Eligibility parameters (for contrast scans within 4 weeks of gadolinium injection): C. Creatinine below upper normal limit D. eGFR \>= 60 mL/min/1.73m2 E. Age \>= 60 or history of renal disease: test GFR within 1 week prior to contrast F. Willing to travel to the NIH for follow-up visits. G. 18 years old H. Able to understand and sign informed consent I. No MRI scan with gadolinium injection in the last 6 months under this protocol. EXCLUSION CRITERIA: A. Implanted metal clips or wires of the type which may concentrate radiofrequency fields or cause tissue damages from twisting in a Magnetic field. Examples: * Aneurysm clip, implanted neural stimulator, * Implanted cardiac pacemaker, defibrillator, or certain other implanted electrical or metallic devices, * Cochlear implant, ocular foreign body (metal shavings), * Any implanted device (pumps, infusion devices, etc.), * Shrapnel injuries, * History of metal in head or eyes or other parts of the body. B. Pregnant women C. Paralyzed hemidiaphragm D. Over 500 lbs and/or a body circumference that prevents the study subject from laying flat in the scanner E. Surgery of uncertain type F. Untreatable claustrophobia otherwise requiring anesthesia. G. Any contraindications that the Physician identifies from the subject, MRI Safety Questionnaire, and/or History and Physical. EXCLUSION FOR PARTICIPANTS FOR GADOLINIUM CONTRAST: (Inclusive of the above exclusion criteria): A. Allergy to gadolinium for scans using contrast; will be eligible for non-contrast scans. B. Acute renal failure, renal transplant, dialysis and renal failure individuals (eGFR \<60 mL/min/1.73m2 and/or clinically diagnosed). C. Individuals with a history of liver transplant or severe liver disease. D. Lactating women E. Individuals with hemoglobinopathies or severe asthma. F. Patient preference to not undergo intravenous line placement and/or receive gadolinium contrast. Contrast administration is optional and participants may still undergo a non-contrast study. G. GBCA with an MRI scan in the last 6 months. This includes scan performed with GBCA at any outside institution and / or at the clinical center .In addition, they cannot have reached their maximum of 4 GBCA imaging studies under this protocol. They will be excluded from having a contrast enhanced MRI, but will not be excluded from the protocol for non-contrast MRI studies.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac risk factors are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.